Similar articles for PMID: 14571156

Year	Number of Results
1997	1
1999	1
2000	2
2001	6
2002	6
2003	8
2004	9
2005	15
2006	4
2007	10
2008	11
2009	6
2010	16
2011	7
2012	3
2013	9
2014	1
2015	1
2016	1
2017	1
2018	1
2019	3
2020	5
2021	1
2022	2
2024	0

1

Reversal of antipsychotic-induced weight gain during quetiapine treatment.

Koponen H, Larmo I. Koponen H, et al. Int Clin Psychopharmacol. 2003 Nov;18(6):355-6. doi: 10.1097/00004850-200311000-00007. Int Clin Psychopharmacol. 2003. PMID: 14571156

2

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Atmaca M, et al. J Clin Psychiatry. 2003 May;64(5):598-604. doi: 10.4088/jcp.v64n0516. J Clin Psychiatry. 2003. PMID: 12755665

3

Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report.

Sacchetti E, Valsecchi P. Sacchetti E, et al. Int Clin Psychopharmacol. 2003 Nov;18(6):357-9. doi: 10.1097/00004850-200311000-00008. Int Clin Psychopharmacol. 2003. PMID: 14571157

4

Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.

Mukundan A, Faulkner G, Cohn T, Remington G. Mukundan A, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006629. doi: 10.1002/14651858.CD006629.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154372 Review.

5

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.

Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, García-Portilla MP, Fernández I, Hernández G; EIRE Study Group. Bobes J, et al. Schizophr Res. 2003 Jul 1;62(1-2):77-88. doi: 10.1016/s0920-9964(02)00431-0. Schizophr Res. 2003. PMID: 12765747

6

Weight gain and antipsychotics.

Mackin P. Mackin P. J Clin Psychiatry. 2005 Jul;66(7):950-1; author reply 951. doi: 10.4088/jcp.v66n0722c. J Clin Psychiatry. 2005. PMID: 16013917 No abstract available.

7

Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.

Kelly DL, Kreyenbuhl J, Love RC, Van-Duong Q, Conley RR. Kelly DL, et al. J Clin Psychiatry. 2003 Sep;64(9):1133-4. doi: 10.4088/jcp.v64n0921f. J Clin Psychiatry. 2003. PMID: 14628994 No abstract available.

8

Quetiapine versus other atypical antipsychotics for schizophrenia.

Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S. Asmal L, et al. Cochrane Database Syst Rev. 2013 Nov 18;(11):CD006625. doi: 10.1002/14651858.CD006625.pub3. Cochrane Database Syst Rev. 2013. PMID: 24249315 Review.

9

Quetiapine-induced myoclonus.

Velayudhan L, Kirchner V. Velayudhan L, et al. Int Clin Psychopharmacol. 2005 Mar;20(2):119-20. doi: 10.1097/00004850-200503000-00011. Int Clin Psychopharmacol. 2005. PMID: 15729090

10

Quetiapine-induced weight gain and escitalopram.

Holzer L, Paiva G, Halfon O. Holzer L, et al. Am J Psychiatry. 2005 Jan;162(1):192-3. doi: 10.1176/appi.ajp.162.1.192-a. Am J Psychiatry. 2005. PMID: 15625223 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

120 results

Results by year